Curis | CRIS - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 5.87B 1.02B 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
CSL USD 4.46B 2.71B 2025-12
Curis USD 1.14M 8.86M 2025-12
Eli Lilly USD 16.22B 301.7M 2026-03
Exelixis USD 608.03M 17.17M 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Incyte USD 1.57B 400.89M 2026-06
Merck USD 12.09B 1.24B 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
Takeda JPY 813.22B 124.39B 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06
Verastem USD 15.62M 977K 2026-03